Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up ...

Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up ...

Experts debate which patients with stage III dMMR colon cancer will benefit from the two treatment approaches.

Raymond James analyst Andrew Cooper maintained a Buy rating on Avantor today and set a price target of $14.00. The company’s shares closed last Friday at $11.36. Take advantage of TipRanks Premium at ...

The global Liquid Biopsy Market, valued at US$3.65 billion in 2024 stood at US$4.03 billion in 2025 and is projected to ...

According to Research by SNS Insider, Global Laboratory Developed Tests Market Growth is Fueled by Rising Demand for Personalized Diagnostics and Chronic Disease Detection.Austin, Aug. 05, 2025 (GLOBE ...